Pradžia › Beta talasemija › New York
Beta talasemija klinikiniai tyrimai New York
5 tyrimai dėl Beta talasemija ieško dalyvių vietose New York.
Oficialus tyrimo tekstas (anglų kalba)
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- New York Presbyterian Hospital, New York
Renkami dalyviai2 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-07-10 · NCT04143724A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
Renkami dalyviai2 fazė
Amžius nuo 2 iki 50 · Visoms lytims · Atnaujinta 2026-06-03 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Renkami dalyviai3 fazė
Amžius nuo 12 iki 35 · Visoms lytims · Atnaujinta 2026-03-23 · NCT05477563AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
Renkami dalyviai2 fazė
1 Day – 30 Years · Visoms lytims · Atnaujinta 2025-08-08 · NCT04099966A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
- Cohen Children's Medical Center, New Hyde Park
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-02-11 · NCT06271512Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.